The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Osteosarcoma: a review of current and future therapeutic approaches
Open accessAbstract
Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally. The incidence of OS is common in the metaphysis of long tubular bones, but rare in the spine, pelvis, and sacrum areas; moreover, majority of the OS patients present with only a single lesion. OS has a bimodal distribution pattern, that is, its incidence peaks in the second decade of life and in late adulthood. We examine historical and current literature to present a succinct review of OS. In this review, we have discussed the types, clinical diagnosis, and modern and future treatment methods of OS. The purpose of this article is to inspire new ideas to develop more effective therapeutic options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Isakoff, M. S., Bielack, S. S., Meltzer, P., & Gorlick, R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4895 · Cited by 1,567
Osteosarcoma treatment – Where do we stand? A state of the art review
Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,234
Ritter, J., & Bielack, S. S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq276 · Cited by 1,045
Moolten, F. L. (1986) · PubMed · Cited by 972
WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition
Jo, V. Y., & Fletcher, C. D. M. (2014) · Pathology · doi:10.1097/pat.0000000000000050 · Cited by 971
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24320 · Cited by 791
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hogendoorn, P. C. W., Athanasou, N., Bielack, S., De Alava, E., Dei Tos, A. P., Ferrari, S., Gelderblom, H., Grimer, R., Sundby Hall, K., Hassan, B., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq223 · Cited by 718
Current and future therapeutic approaches for osteosarcoma
Harrison, D. J., Geller, D. S., Gill, J. D., Lewis, V. O., & Gorlick, R. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1413939 · Cited by 689
Common Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., & Crist, W. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410507 · Cited by 657
Nanocarriers for cancer-targeted drug delivery
Kumari, P., Ghosh, B., & Biswas, S. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1051049 · Cited by 607
Update on Survival in Osteosarcoma
Anderson, M. E. (2016) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2015.08.022 · Cited by 560
Osteosarcoma: a comprehensive review
Misaghi, A., Goldin, A., Awad, M., & Kulidjian, A. A. (2018) · SICOT-J · doi:10.1051/sicotj/2017028 · Cited by 517
Osteosarcoma: a review of diagnosis, management, and treatment strategies.
Geller, D. S., & Gorlick, R. G. (2010) · PubMed · Cited by 475
Winkler, K., Beron, G., Delling, G., Heise, U., Kabisch, H., Purfürst, C., Berger, J., Ritter, J., Jürgens, H., & Gerein, V (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.329 · Cited by 459
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 412
Osteosarcoma: Anatomic and Histologic Variants
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6kqhld9lv2kenn · Cited by 386
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6k-qhld-9lv2-kenn · Cited by 367
Moore, D. D., & Luu, H. H. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-319-07323-1_4 · Cited by 349
Current concepts review. The surgical staging of musculoskeletal sarcoma.
Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1980) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198062060-00028 · Cited by 334
Radiotherapy for local control of osteosarcoma
DeLaney, T. F., Park, L., Goldberg, S. I., Hug, E. B., Liebsch, N. J., Munzenrider, J. E., & Suit, H. D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.051 · Cited by 306
Meyers, P. A., & Gorlick, R. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70540-x · Cited by 299
Common Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., Rose, P. S., Folpe, A. L., & Laack, N. N. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.01.015 · Cited by 298
The many faces of osteosarcoma.
Murphey, M. D., Robbin, M. R., McRae, G. A., Flemming, D. J., Temple, H. T., & Kransdorf, M. J. (1997) · RadioGraphics · doi:10.1148/radiographics.17.5.9308111 · Cited by 287
Messerschmitt, P. J., Garcia, R. M., Abdul-Karim, F. W., Greenfield, E. M., & Getty, P. J. (2009) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-200908000-00005 · Cited by 260
Link, M., Goorin, A. M., Horowitz, M. M., et al. (1991) · PubMed · Cited by 259
Simpson, E., & Brown, H. L. (2018) · JAAPA · doi:10.1097/01.jaa.0000541477.24116.8d · Cited by 233
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
Ferrari, S., & Palmerini, E. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328122d73f · Cited by 219
Kaste, S. C., Pratt, C. B., Cain, A. M., Jones-Wallace, D. J., & Rao, B. N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1602::aid-cncr31>3.0.co;2-r · Cited by 215
Eaton, B. R., Schwarz, R., Vatner, R., Yeh, B., Claude, L., Indelicato, D. J., & Laack, N. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.28352 · Cited by 215
An update on chemotherapy for osteosarcoma
Ferrari, S., & Serra, M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1102226 · Cited by 213
Mohamad, O., Sishc, B., Saha, J., Pompos, A., Rahimi, A., Story, M., Davis, A., & Kim, D. W. (2017) · Cancers · doi:10.3390/cancers9060066 · Cited by 200
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
PosthumaDeBoer, J., Witlox, M. A., Kaspers, G. J. L., & van Royen, B. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9384-x · Cited by 194
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y., Yock, T. I., Ebb, D. H., Choy, E., Raskin, K. A., Liebsch, N., et al. (2011) · Cancer · doi:10.1002/cncr.26037 · Cited by 191 · cited 1×
“[83] demonstrated that proton therapy provides a highdose radiation therapy for local treatment of patients with unresectable or incompletely removed OS.”
BackgroundImmunotherapy for osteosarcoma: Where do we go from here?
Wedekind, M. F., Wagner, L. M., & Cripe, T. P. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27227 · Cited by 172
LINK, M. P., GOORIN, A. M., HOROWITZ, M., MEYER, W. H., BELASCO, J., BAKER, A., AYALA, A., & SHUSTER, J. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00003 · Cited by 171
Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines
Honoki (2009) · International Journal of Oncology · doi:10.3892/ijo_00000265 · Cited by 163
Kayton, M. L., Huvos, A. G., Casher, J., et al. (2006) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2005.10.024 · Cited by 157
Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the Extremities
Machak, G. N., Si, T., Solovyev, Y. N., Sinyukov, P. A., Ivanov, S. M., Кочергина, Н. В., Ryjkov, A. D., Тепляков, В. В., Bokhyan, B. Y., & Glebovskaya, V. V. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.2.147 · Cited by 149
Recent advances of drug delivery nanocarriers in osteosarcoma treatment
Wang, S., Hu, H.-Z., Qing, X.-C., Zhang, Z., & Shao, Z.-W. (2019) · Journal of Cancer · doi:10.7150/jca.36588 · Cited by 140
Skip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
Kager, L., Zoubek, A., Kastner, U., Kempf‐Bielack, B., Potratz, J. C., Kotz, R. I., Exner, G. U., Franzius, C., Lang, S., Maas, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2978 · Cited by 139
Immunotherapy: Bewitched, Bothered, and Bewildered No More
Steinman, R. M., & Mellman, I. (2004) · Science · doi:10.1126/science.1099688 · Cited by 136
Current and Emerging Targets in Immunotherapy for Osteosarcoma
Miwa, S., Shirai, T., Yamamoto, N., Hayashi, K., Takeuchi, A., Igarashi, K., & Tsuchiya, H. (2019) · Journal of Oncology · doi:10.1155/2019/7035045 · Cited by 126
Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma
Marulanda, G. A., Henderson, E. R., Johnson, D. A., Letson, G. D., & Cheong, D. (2008) · Cancer Control · doi:10.1177/107327480801500103 · Cited by 125
Osteosarcoma Multidisciplinary Approach to the Management from the Pathologist’s Perspective
Raymond, A. K., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_4 · Cited by 125
Advances in limb salvage treatment of osteosarcoma
Yang, Y., Han, L., He, Z., Li, X., Yang, S., Yang, J., Zhang, Y., Li, D., Yang, Y., & Yang, Z. (2017) · Journal of bone oncology · doi:10.1016/j.jbo.2017.11.005 · Cited by 110
Isolated paraaortic lymph‐node recurrence after the curative resection of colorectal carcinoma
Min, B. S., Kim, N. K., Sohn, S. K., Cho, C. H., Lee, K. Y., & Baik, S. H. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20926 · Cited by 108
Bajpai, J., Gamnagatti, S., Kumar, R., Sreenivas, V., Sharma, M. C., Khan, S. A., Rastogi, S., Malhotra, A., Safaya, R., & Bakhshi, S. (2010) · Pediatric Radiology · doi:10.1007/s00247-010-1876-3 · Cited by 107
Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment
Kumar, R., Kumar, M., Malhotra, K., & PATEL, S. R. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0658-1 · Cited by 102
Schwartz, C. L., Wexler, L. H., Krailo, M., Teot, L. A., Devidas, M., Steinherz, L. J., Goorin, A. M., Gebhardt, M. C., Healey, J. H., Sato, J. K., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25753 · Cited by 99
Stereotactic Body Radiotherapy for Metastatic and Recurrent Ewing Sarcoma and Osteosarcoma
Brown, L. C., Lester, R. A., Grams, M. P., Haddock, M. G., Olivier, K. R., Arndt, C. A. S., Rose, P. S., & Laack, N. N. (2014) · Sarcoma · doi:10.1155/2014/418270 · Cited by 99
The Incidence and Prognosis of Osteosarcoma Skip Metastases
Sajadi, K. R., Heck, R. K., Neel, M. D., Rao, B. N., Daw, N. C., Galindo, C. R., Hoffer, F. A., Stacy, G. S., Peabody, T. D., & Simon, M. A. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000141493.52166.69 · Cited by 97
Treatment of osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group (COSS)
Winkler, K., Bielack, S. S., Delling, G., et al. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3518-8_32 · Cited by 91
Sampo, M. M., Koivikko, M. P., Taskinen, M. H., Kallio, P., Kivioja, A., Tarkkanen, M., & Böhling, T. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.615339 · Cited by 85
Whelan, J., Seddon, B. M., & Perisoglou, M. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0020-y · Cited by 84
A comparative study between limb-salvage and amputation for treating osteosarcoma
Li, X., Zhang, Y. P., Wan, S., Li, H., Li, D., Xia, J., Yuan, Z., Ren, M., Yu, S., Li, S., et al. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.01.001 · Cited by 78
The Evolving Role of Proton Beam Therapy for Sarcomas
Frisch, S., & Timmermann, B. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.04.034 · Cited by 78
Guideline for Limb‐Salvage Treatment of Osteosarcoma
Xu, M., Wang, Z., Yu, X., Lin, J., & Hu, Y. (2020) · Orthopaedic Surgery · doi:10.1111/os.12702 · Cited by 74
Cinti, C., Claudio, P. P., Howard, C. M., Neri, L. M., Fu, Y., Leoncini, L., Tosi, G. M., Maraldi, N. M., & Giordano, A. (2000) · PubMed · Cited by 73
Kim, H. J., Chalmers, P. N., & Morris, C. D. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328334581f · Cited by 72
Bone sarcomas: Overview of management, with a focus on surgical treatment considerations
Lietman, S. A., & Joyce, M. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77.s1.02 · Cited by 69
Osteosarcoma: Current status of immunotherapy and future trends (Review)
Mori, K., Rédiní, F., Gouin, F., Cherrier, B., & Heymann, D. (2006) · Oncology Reports · doi:10.3892/or.15.3.693 · Cited by 69
Multimodality treatment of osteosarcoma: Radiation in a high‐risk cohort
Mahajan, A., Woo, S. Y., Kornguth, D. G., Hughes, D. P. M., Huh, W. W., Chang, E. L., Herzog, C. E., Pelloski, C. E., & Anderson, P. M. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21451 · Cited by 68
Prognosis of Osteosarcoma With Pulmonary Metastases at Initial Presentation Is Not Dismal
YONEMOTO, T., Tatezaki, S., Ishii, T., Satoh, T., Kimura, H., & Iwai, N. (1998) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199804000-00024 · Cited by 61
Meazza, C., Cefalo, G., Massimino, M., Daolio, P. A., Pastorino, U., Scanagatta, P., Morosi, C., Podda, M. G., Ferrari, A., Terenziani, M., et al. (2017) · Medical Oncology · doi:10.1007/s12032-017-1052-9 · Cited by 50
Russo, C., Lavorgna, M., Česen, M., Kosjek, T., Heath, E., & Isidori, M. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.10.066 · Cited by 50
Oxidative Stress-Regulated Lentiviral TK/GCV Gene Therapy for Lung Cancer Treatment
Leinonen, H. M., Ruotsalainen, A., Määttä, A., Laitinen, H. M., Linna-Kuosmanen, S., Kansanen, E., Pikkarainen, J. T., Lappalainen, J. P., Samaranayake, H. D., Lesch, H. P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1166 · Cited by 45
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines
Ye, S., Shen, J. K., Choy, E., Cao, Y., Mankin, H. J., Hornicek, F. J., & Duan, Z. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2944-z · Cited by 45
Global incidence of primary malignant bone tumors
Kumar, N., & Gupta, B. (2016) · Current Orthopaedic Practice · doi:10.1097/bco.0000000000000405 · Cited by 44
Initial tumor size predicts histologic response and survival in localized osteosarcoma patients
Kim, M. S., Lee, S., Cho, W. H., Song, W. S., Koh, J., Lee, J. A., Yoo, J. Y., & Jeon, D. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.20986 · Cited by 41
Open questions in the treatment of cancer pain: time for a strong evidence-based approach?
Natoli, S., Lazzari, M., & Dauri, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.980724 · Cited by 36
Ferrari, S. M., Mercuri, M., Bacci, G., Bielack, S., & Jürgens, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.12.2910 · Cited by 31
Osteosarcoma. Results of treatment employing adjuvant immunotherapy.
Eilber, F. R., Townsend, C. M., & Morton, D. L. (1975) · PubMed · Cited by 23
Marshall, J.-C. A., Bakalian, S., & Martins, C. M. D. O. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3685-0_4 · Cited by 21
Eilber, F. R., Townsend, C. M., & Morton, D. L. (1975) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197509000-00012 · Cited by 20
Is There a Role for Immunotherapy in Osteosarcoma?
Loeb, D. M. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_25 · Cited by 19
Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
Ru, J., Cong, Y., Kang, W., Yu, L., Guo, T., & Zhao, J. (2015) · PubMed · Cited by 19
Osteosarcoma: Current concepts, challenges and future directions
Oryan, A., Alidadi, S., & Moshiri, A. (2014) · Current Orthopaedic Practice · doi:10.1097/bco.0000000000000199 · Cited by 17
Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma
Wu, J., Guo, A., Li, Q., & Wang, D. (2017) · Future Oncology · doi:10.2217/fon-2017-0180 · Cited by 16
Imaging of Malignant Skeletal Tumors
Pahade, J. K., Sekhar, A. K., & Shetty, S. K. (2008) · Cancer treatment and research · doi:10.1007/978-0-387-75587-8_15 · Cited by 14
Tratamiento del osteosarcoma. Revisión
Majó, J. B., Cubedo, R., & Pardo, N. (2010) · Revista Española de Cirugía Ortopédica y Traumatología · doi:10.1016/j.recot.2010.05.006 · Cited by 12
Making gene therapy for osteosarcoma a reality
Broadhead, M. L., Clark, J. C. M., Choong, P., & Dass, C. R. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.18 · Cited by 12
Osteosarcoma: the experiences of a specialist unit
Pringle, J. A. S. (1996) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(05)80010-9 · Cited by 10
Current advances in osteosarcoma
Kleinerman, E. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-4843_7 · Cited by 9
Current Advances in Osteosarcoma
Kleinerman, E. S., & Gorlick, R. G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43032-0 · Cited by 7
Value of dynamic magnetic resonance imaging in preoperative evaluation of pediatric osteosarcoma
Farghaly, R., Zaki, I., Gouda, I., Abdelfatah, M., Ghoneimy, A. M. E., Sherbiny, M. E., Soliman, R., & Zamzam, M. (2016) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1016/j.ejrnm.2016.06.022 · Cited by 4
Current Status of Immunotherapy for Osteosarcoma and its Future Trends
Mori, K., Ando, K., Matsusue, Y., & Heymann, D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374895-9.00034-7 · Cited by 2
Diagnosis and Progress in Biological Treatment of Osteosarcoma
谢, 欣. (2019) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2019.93017 · Cited by 1
Cited by
Naringenin: A potential flavonoid phytochemical for cancer therapy
Motallebi, M., Bhia, M., Rajani, H. F., Bhia, I., Tabarraei, H., Mohammadkhani, N., Pereira-Silva, M., Kasaii, M. S., Nouri-Majd, S., Mueller, A.-L., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120752 · Cited by 328
Cellular crosstalk in the bone marrow niche
Huang, Z., Iqbal, Z., Zhao, Z., Liu, J., Alabsi, A. M., Shabbir, M., Mahmood, A., Liang, Y., Li, W., & Deng, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05900-6 · Cited by 34
Self-citationDong, C., Wang, Z., Shen, P., Chen, Y., Wang, J., & Wang, H. (2022) · Bioengineered · doi:10.1080/21655979.2022.2051805 · Cited by 25
Metadata
- Authors
- Zhao, X., Wu, Q., Gong, X., Liu, J., & Ma, Y.
- Venue
- BioMedical Engineering OnLine
- Published
- 2021-03-02
- Volume
- 20
- Issue
- 1
- Pages
- 24-24
- ISSN
- 1475-925X (ISSN-L)
- OpenAlex
- W3133782202
- Cited by
- 312
- References
- 92
- FWCI
- 29.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.